TNGX

Tango Therapeutics, Inc.

25.53

USD

+3.20

+14.33%

Sep 22, 15:59 UTC -4

Closed

Pre-Market

25.18

-0.36

-1.39%

Tango Therapeutics, Inc. Profile

About

Tango Therapeutics Inc. is a biotechnology company. It focused on discovering and delivering precision cancer medicines. Tango Therapeutics Inc., formerly known as BCTG Acquisition Corp., is based in CAMBRIDGE, Mass.

Info & Links

CEO

Malte Peters

Headquarters

201 BROOKLINE AVE. SUITE 901
BOSTON, MA 02215, UNITED STATES

Auditor

PricewaterhouseCoopers LLP

Share holders

Employees

137

Tango Therapeutics, Inc. Statistics

Valuation Measures

Market Capitalization²

4.24B

Enterprise Value

3.90B

Enterprise Value/EBITDA(ttm)

-28.29

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

55.15

Price to Book(mrq)

3.07

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

25.00%

Operating Margin(ttm)

Profit Margin(ttm)

7.38%

Return on Equity(ttm)

-25.75%

Return on Invested Capital(ttm)

-18.29%

Return on Assets(ttm)

-23.36%

Income Statement

Revenue(ttm)

53.81M

Revenue Per Share(ttm)

0.32

Gross Profit(ttm)

53.81M

EBITDA(ttm)³

-137.82M

Net Income Available to Common(ttm)

-123.72M

Diluted EPS(ttm)

-0.85

Share Statistics

Beta (5Y Monthly)

1.12

52-Week Change

242.68%

S&P 500 52-Week Change

17.10%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

168.61M

Dividend Yield

0.00%

Float⁴

157.65M

% Held by Insiders

6.50%

% Held by Institutions

78.99%

Balance Sheet

Total Cash(mrq)

1.01B

Total Cash Per Share(mrq)

6.01

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

50.82%

Quick Ratio(mrq)

50.82%

Book Value Per Share(mrq)

6.08

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.56

Free Cash Flow(ytd)

-83.20M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.